New Jersey is set to receive $641 million from settlements with Johnson & Johnson, which manufactured opioids, and the country’s three largest pharmaceutical distributors – McKesson, Cardinal Health, and AmerisourceBergen, according to Governor Phil Murphy and Acting Attorney General Matt Platkin.
The award will be paid through 2038 and will fund state and local programs focused on treatment, prevention, and other strategies to combat the opioid epidemic in the state, with 50 percent going to the State and 50 percent going to counties and municipalities.
“This is a historic moment in our fight to combat the opioid crisis in New Jersey and save lives,” Murphy said. “With these historic funds, we will continue to make critical investments in harm reduction centers, treatment programs, and data-driven strategies to end the overdose crisis. With these funds, coupled with the nearly $100 million investment in my proposed budget, we will continue our work to combat the opioid crisis in New Jersey.”